Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients


Unal S., Ozdemir O., Ozcimen A. A. , Oztas Y.

INTERNATIONAL JOURNAL OF HEMATOLOGY, vol.101, no.2, pp.114-118, 2015 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 101 Issue: 2
  • Publication Date: 2015
  • Doi Number: 10.1007/s12185-014-1718-4
  • Journal Name: INTERNATIONAL JOURNAL OF HEMATOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus
  • Page Numbers: pp.114-118

Abstract

In the present study, we examined the role of fractalkine (Fkn), a member of the chemokine family, in the pathogenesis of sickle cell disease (SCD). Eighty-seven children with sickle cell disease and 55 healthy children were enrolled in the study. Complete blood counts, serum levels of C-reactive protein, tumor necrosis factor-alpha, interferon-gamma and fractalkine, and gene expression levels of Fkn were investigated. Serum Fkn levels and Fkn gene expression values were significantly higher in the SCD group compared to control group (P < 0.05). The findings of elevated serum Fkn and Fkn gene expression in both vaso-occlusive crisis and stable forms of SCD suggest that this chemokine may be involved in the pathogenesis of inflammation observed in SCD. This study is the first to our knowledge to describe the relationship of Fkn and inflammation in SCD.